Article

Test Yourself on Osteoporosis Testing

A quiz in JAMA uses a case with discordant DXA results to discuss the options in assessment of hip fracture risk in osteoporosis, describing their advantages and drawbacks.

Neuner J, Carnahan J. Dual X-ray Absorptiometry for Diagnosis of Osteoporosis. JAMA (2014) 312:1147-1148. doi:10.1001/jama.2014.1402. Online September 17, 2014

This quiz uses dual x-ray absorptiometry (DXA), in the context of the United States Preventive Services Task Force (USPSTF) recommendations, to evaluate a patient, develop a treatment plan, and explain the benefits of therapy to the patient.

The patient is a white woman, 69, with discordant T Scores. The spinal T Score, -3.1, is in the osteoporosis range, but the femoral neck T Score, -2.1, is not. A T score of -2.5 is only 64% sensitive and 84% specific for hip fracture risk, and fewer than half of women with hip fractures actually had osteoporosis.

By expert consensus, osteoporosis is diagnosed in postmenopausal women when either a central (spine or femoral neck) DXA is ≥2.5 standard deviations below a young adult reference mean (T score <2.5), and other causes of low bone density are excluded. So she is diagnosed with osteoporosis.

The text discusses the details of recommended alternative testing methods, including their drawbacks.

In this case, the patient's fracture risk was calculated at 5 times that of a young healthy women. The answer reveals her adjusted osteoporotic fracture risk, compares it with the risk after alendronate treatment, and reveals what happened.

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.